Among patients with heart failure and a preserved ejection (HFpEF), obesity is associated
with a distinct phenotype that is characterized by adiposity‐driven plasma volume expansion …

Obesity-related heart failure with a preserved ejection fraction (HFpEF) is an important
phenotype prevalent in the community, especially in people with metabolic disorders (eg …

Obesity (especially visceral adiposity) can be associated with 3 different phenotypes of heart
failure: heart failure with a reduced ejection fraction, heart failure with a preserved ejection …

Obesity and heart failure with preserved ejection fraction (HFpEF) represent two
intermingling epidemics driving perhaps the greatest unmet health problem in …

Aims There is increasing evidence of cross‐talk between the heart, body metabolism, and
adipose tissue, but the precise mechanisms are poorly understood. Natriuretic peptides …

Heart failure with preserved ejection fraction (HFpEF) is a major unmet medical need that is
characterized by the presence of multiple cardiovascular and non-cardiovascular …

Background—Despite the increasing prevalence of heart failure with preserved ejection
fraction (HFpEF) in humans, there are no evidence-based therapies for HFpEF. Clinical …

Heart failure (HF) has interesting relationships with some of its risk factors. For example,
both high blood pressure and smoking are risk factors for incident HF, but for patients with …

Heart failure with a preserved ejection fraction (HFpEF) and heart failure with a reduced
ejection fraction (HFrEF) have distinctive pathophysiologies, and thus, therapeutic …

Heart failure with preserved ejection fraction (HFpEF) is characterized by signs and
symptoms of heart failure in the presence of a normal left ventricular ejection fraction …